| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.MED.53.082901.104011 |
| P698 | PubMed publication ID | 11818468 |
| P50 | author | Bruce D. Walker | Q23770361 |
| P2093 | author name string | Rajesh T Gandhi | |
| P2860 | cites work | Quantifying the uncertainty in forecasts of anthropogenic climate change | Q28141336 |
| HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death | Q35159818 | ||
| P304 | page(s) | 149-172 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Annual Review of Medicine | Q567363 |
| P1476 | title | Immunologic control of HIV-1. | |
| P478 | volume | 53 |
| Q44791801 | A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent |
| Q34335916 | A look behind closed doors: interaction of persistent viruses with dendritic cells |
| Q81918606 | A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes |
| Q28751663 | A vaccine encoding conserved promiscuous HIV CD4 epitopes induces broad T cell responses in mice transgenic to multiple common HLA class II molecules |
| Q27489000 | Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates |
| Q36600380 | Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. |
| Q28482252 | Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine |
| Q36092837 | Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy. |
| Q34437641 | Associations of host genetic variants on CD4⁺ lymphocyte count and plasma HIV-1 RNA in antiretroviral naïve children |
| Q30332080 | Beyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues. |
| Q56772813 | Bupivacaine enhances the magnitude and longevity of HIV-specific immune response after immunization with a CD4 epitope-based DNA vaccine |
| Q43955957 | CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms |
| Q36012455 | CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals |
| Q33717736 | Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice |
| Q27675568 | Crystal Structure of the HLA-DM–HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection |
| Q35917144 | Cytokine therapies in HIV-1 infection: present and future |
| Q38511530 | DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice |
| Q45603036 | Deliberate removal of T cell help improves virus-neutralizing antibody production. |
| Q27010312 | Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle? |
| Q33874652 | Dendritic cell-based human immunodeficiency virus vaccine |
| Q55365295 | Differentiation and Function of Follicular CD8 T Cells During Human Immunodeficiency Virus Infection. |
| Q27675464 | Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity |
| Q35023530 | Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV. |
| Q36086229 | Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif |
| Q33819656 | Emerging nanotechnology approaches for HIV/AIDS treatment and prevention |
| Q39709538 | Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP. |
| Q41880425 | Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire |
| Q47926468 | Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection |
| Q27314881 | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response |
| Q26995220 | Genetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure? |
| Q37034594 | HIV-1-specific immune response. |
| Q35024026 | HLA alleles are associated with altered risk for disease progression and central nervous system impairment of HIV-infected children |
| Q37232884 | HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection |
| Q83003156 | High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts |
| Q35095654 | Host Genetic Factors and Dendritic Cell Responses Associated with the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals |
| Q35857651 | Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point |
| Q36315692 | Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants |
| Q36509838 | IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection |
| Q37059821 | Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual |
| Q93000948 | Immune Control of HIV |
| Q38924824 | Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV. |
| Q42214247 | In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth. |
| Q27477561 | Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development |
| Q41842825 | Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection |
| Q36841404 | Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys |
| Q90401227 | Lovastatin Inhibits HIV-1-Induced MHC-I Downregulation by Targeting Nef-AP-1 Complex Formation: A New Strategy to Boost Immune Eradication of HIV-1 Infected Cells |
| Q35880187 | Maternal malaria and perinatal HIV transmission, western Kenya |
| Q37333777 | Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection |
| Q43047909 | Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response |
| Q34265962 | Novel engineered HIV-1 East African Clade-A gp160 plasmid construct induces strong humoral and cell-mediated immune responses in vivo |
| Q44581919 | Optimization of methods to assess human mucosal T-cell responses to HIV infection. |
| Q79772747 | Overlapping synthetic peptides as vaccines |
| Q41928139 | Precise identification of a human immunodeficiency virus type 1 antigen processing mutant |
| Q36602269 | Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases |
| Q34712708 | Promises and pitfalls in the reconstitution of immunity in patients who have HIV-1 infection |
| Q50281273 | Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine. |
| Q30358493 | Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. |
| Q45386726 | Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses |
| Q61771037 | Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model |
| Q33911986 | Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies |
| Q33383193 | Role of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy |
| Q44965239 | Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication. |
| Q33655043 | Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action |
| Q30427403 | Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases |
| Q36409885 | Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation |
| Q54210140 | Targeting the Latent Reservoir for HIV-1. |
| Q36215709 | The ABCs of Trait Anger, Psychological Distress, and Disease Severity in HIV. |
| Q24629787 | The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1 |
| Q36496904 | The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life |
| Q28481573 | Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques |
| Q37077668 | Vaccination against drug resistance in HIV infection |
| Q51996451 | [Changes in CD4+ and CD8+ T-cell subsets in HIV-infected children differently correlate with viral replication and thymic function]. |
Search more.